

Learn about common and serious Envarsus XR side effects, who's most at risk, how to manage them, and when to seek medical help right away.
Envarsus XR (Tacrolimus extended-release) is a powerful immunosuppressant that helps prevent organ rejection after a kidney transplant. It works — but like all medications that suppress your immune system, it comes with side effects that you need to understand. Some are mild and manageable. Others need immediate medical attention.
This guide breaks down what to expect, what to watch for, and when to pick up the phone and call your doctor.
Envarsus XR is a once-daily, extended-release tablet form of Tacrolimus, a calcineurin inhibitor. It's made by Veloxis Pharmaceuticals and is used to prevent kidney transplant rejection. If you want a deeper dive, check out our full guide on what Envarsus XR is and how it's used.
These side effects are reported frequently in clinical trials. Many patients experience at least one of them, especially in the first few months after starting the medication:
These side effects don't always mean something is wrong. Your body is adjusting to a strong medication, and many of these improve over time. But you should still report them to your transplant team so they can track patterns and adjust your dose if needed.
Envarsus XR carries a boxed warning — the FDA's most serious warning level — about the risk of infections and cancer. Here are the serious side effects to be aware of:
Because Envarsus XR suppresses your immune system, your body is less able to fight off infections. These can include bacterial, viral, fungal, and protozoal infections. Some can become life-threatening. Watch for:
Long-term use of immunosuppressants, including Tacrolimus, increases the risk of lymphoma and other malignancies, particularly post-transplant lymphoproliferative disorder (PTLD). Your doctor will monitor you regularly for signs of cancer, including unusual lumps, unexplained weight loss, or night sweats.
Ironically, the drug meant to protect your transplanted kidney can also damage it if levels get too high. This is why regular blood monitoring of Tacrolimus trough levels is so critical. Symptoms of kidney problems include decreased urination, swelling, and unexplained weight gain.
In rare cases, Envarsus XR can cause serious neurological side effects including:
Tacrolimus can trigger diabetes in people who didn't have it before their transplant. Your doctor will monitor your blood sugar levels regularly. Symptoms include increased thirst, frequent urination, and blurred vision.
QT prolongation — a change in the electrical activity of your heart — has been reported. Tell your doctor immediately if you experience a racing heartbeat, dizziness, or fainting.
Some patients face elevated risks for certain side effects:
Here are practical tips for dealing with the most common issues:
The most important thing you can do is keep your blood monitoring appointments. Your Tacrolimus trough level tells your doctor if the dose is right. Too high means more side effects and potential toxicity. Too low means your transplant is at risk.
Contact your transplant team or go to the emergency room if you experience:
Side effects are a reality of immunosuppressant therapy — but they're manageable when you know what to look for and stay in close contact with your transplant team. Don't skip blood work, don't adjust your dose on your own, and don't ignore symptoms that feel "off."
If cost or availability is making it hard to stay on Envarsus XR consistently, explore savings programs or use Medfinder to find it in stock near you. Consistency with this medication is everything.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.